Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
BMC Health Services Research|April 23, 2022
Evaluating the implementation and impact of navigator-supported remote symptom monitoring and management: a protocol for a hybrid type 2 clinical trialGabrielle B Rocque, J Nicholas Dionne-Odom, Angela M Stover, et al.JAMA Network Open|May 13, 2025
Remote Symptom Monitoring With Electronic Patient-Reported Outcomes in Clinical Cancer PopulationsGabrielle B Rocque, Jeffrey A Franks, Luqin Deng, et al.Translational Behavioral Medicine|September 28, 2013
Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Deborah Watkins Bruner, Laura J Hanisch, Bryce B Reeve, et al.Cancer|November 20, 2020
Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancerKirsten A Nyrop, Allison M Deal, Yi Tang Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trialM Catherine Pietanza, Ethan M Basch, Alex Lash, et al.European Urology|December 12, 2018
Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain EndpointEthan M Basch, Mark Scholz, Johann S de Bono, et al.JCO Oncology Practice|October 28, 2022
Adaptation of Remote Symptom Monitoring Using Electronic Patient-Reported Outcomes for Implementation in Real-World SettingsGabrielle B Rocque, D'Ambra N Dent, Stacey A Ingram, et al.JCO Clinical Cancer Informatics|June 6, 2023
Evaluating Nurses' Time to Response by Severity and Cancer Stage in a Remote Symptom Monitoring Program for Patients With Breast CancerNicole E Caston, Jeffrey A Franks, Nora Balas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion studyMatthew R Smith, Christopher J Sweeney, Paul G Corn, et al.Clinical Genitourinary Cancer|March 10, 2020
Pilot Study of [<sup>18</sup>F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC)Patrick J Eulitt, Ersan Altun, Arif Sheikh, et al.Pageof 8